Smartphone app aims to land blood pressure safely

NCT ID NCT03612271

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a mobile health system called mGlide that helps patients with uncontrolled high blood pressure monitor their BP at home and automatically share readings with their healthcare team. The system alerts doctors when BP goes off track, allowing for timely medication adjustments. The trial includes 395 participants, including stroke survivors and others at high risk for heart disease, from clinics serving low-income and minority communities.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mGlide mobile health system (behavioral intervention using wireless BP monitor and smartphone)
What this could lead to
If successful, this could provide a practical, scalable way to improve blood pressure control in high-risk patients, especially in underserved communities.
What could go wrong
This is a relatively small trial (395 participants) testing a behavioral intervention, not a new drug. Results may not apply to all populations or settings, and long-term adherence to self-monitoring is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Epidemiology Clinical Research Center

    Minneapolis, Minnesota, 55415, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.